Commonwealth Equity Services LLC lifted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 18.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 101,087 shares of the exchange traded fund’s stock after buying an additional 15,460 shares during the quarter. Commonwealth Equity Services LLC owned approximately 0.17% of SPDR S&P Biotech ETF worth $9,691,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Rockefeller Capital Management L.P. acquired a new position in shares of SPDR S&P Biotech ETF during the second quarter worth $130,000. WP Advisors LLC acquired a new stake in SPDR S&P Biotech ETF in the second quarter valued at $133,000. Squar Milner Financial Services LLC acquired a new stake in SPDR S&P Biotech ETF in the second quarter valued at $139,000. Valeo Financial Advisors LLC raised its holdings in SPDR S&P Biotech ETF by 165.2% in the second quarter. Valeo Financial Advisors LLC now owns 1,525 shares of the exchange traded fund’s stock valued at $144,000 after acquiring an additional 950 shares in the last quarter. Finally, Moneta Group Investment Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the second quarter valued at $144,000.

XBI stock traded down $2.51 during trading on Friday, hitting $78.19. 5,388,738 shares of the company’s stock traded hands, compared to its average volume of 4,897,202. SPDR S&P Biotech ETF has a 52 week low of $73.97 and a 52 week high of $101.55.

WARNING: This report was originally posted by Marea Informative and is owned by of Marea Informative. If you are reading this report on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The original version of this report can be viewed at https://www.mareainformativa.com/news/2018/12/08/commonwealth-equity-services-llc-grows-holdings-in-spdr-sp-biotech-etf-xbi-updated-updated-updated.html.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Article: Swap

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.